[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"labral-tear-glenoid\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:labral-tear-glenoid":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100371237","blood-flow-restriction-following-hip-arthroscopy-100371237",false,"NCT04113759","Blood Flow Restriction Following Hip Arthroscopy","Postoperative Blood Flow Restriction Training Following Hip Arthroscopy: A Randomized Clinical Trial","Inclusion Criteria:\n\n* Adult patients 18-40\n* English-speaking\n* Clinical and radiographic examination (MRI) consistent FAIS and\u002For labral pathology, and are schedule for primary hip arthroscopy\n* Written and informed consent for study participation\n\nExclusion Criteria:\n\n* Patients younger than 18 or older than 40 years of age\n* Non-native English speaker\n* Revision surgery or prior history of ipsilateral hip or knee surgery\n* Inability to comply with the proposed follow-up clinic visits\n* Patients lacking decisional capacity\n* Patients with a history of deep vein thrombosis, pulmonary embolism, or known clotting disorder or hypercoagulable state\n* Pregnant or breast-feeding women. Pregnancy as determined by a positive pregnancy test prior to procedure. Females of childbearing potential must agree to use an acceptable birth control method during study participation.\n* Worker's compensation patients\n* Any clinically significant finding that would place the patient at health risk, impact the study, or affect the completion of the study\n* Any psychiatric illness that would prevent comprehension of the details and nature of the study and interfere with follow-up clinic visits",true,"ALL","18 Years","40 Years",{"count":21,"type":22},56,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and\u002For labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will take place at 1-month, 3-months, 6-months, and 1-year.",[28,29],"Labral Tear, Glenoid","Femoral Acetabular Impingement","RECRUITING","2025-12-04",{"date":33,"type":34},"2025-12-05","ACTUAL",{"date":36,"type":34},"2023-08-01",{"date":38,"type":22},"2028-01",{"name":40,"class":41},"Rush University Medical Center","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":23,"phases":53,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":42},"100369773","hip-arthroscopy-postoperative-opioid-demands-100369773","NCT04094701","Hip Arthroscopy Postoperative Opioid Demands","Randomized Control Trial Evaluating Postoperative Opioid Demands Following Hip Arthroscopy","Inclusion Criteria:\n\n* Adult patients age 18-80 years\n* English speaking\n* Opioid naive patient (defined as not taking opioid pills within 6 weeks prior to surgery), confirmed by checking the Illinois Prescription monitoring program\n* Primary hip arthroscopy\n* Written and informed consent for study participation\n\nExclusion Criteria:\n\n* Minors (\\\u003C18 years of age)\n* Opioid tolerant patients\n* Revision surgery\n* Prior infections of the operative joint\n* History of active malignancy within the past 5 years\n* Chronic pain conditions including low back pain, chronic pain syndrome, fibromyalgia\n* History of alcohol or other substance use disorder\n* Other disease states including rheumatologic conditions, diabetes mellitus, hypo\u002Fhyperthyroidism, depression, anxiety\n* Grade IV chondral defects","80 Years",{"count":52,"type":22},170,[25],"This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.",[56,57,29,28],"Opioid Use","Pain","2025-08-05",{"date":60,"type":34},"2025-08-07",{"date":62,"type":34},"2020-10-21",{"date":64,"type":22},"2027-03",{"name":40,"class":41}]